Insider trade

Insider purchased ~$1.78M of GS shares in the open market

Traded Aug 5, 2026 · Filed Aug 14, 2026

Goldman SachsGS

~$1.78M
Reported value · 85K sh @ $21.00: 85K
Holds after · shares reported: -15.4%
stock since the trade · S&P 500 -0.8%, $1,060.38 → $896.67 on Oct 1

Why it stands out

Goldman Sachs's Reporting person spent $1.78M of their very own money to buy Goldman Sachs shares.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Aug 5, 2026
Reporting period: Not applicable
Filed with the SEC: Aug 14, 2026

InsiderIndirect holding$1M+

Context

Classification

open market purchase

Code P — open-market or private purchase

Absolute commitment

~$1,785,000

Shares × reported transaction price

Size band

$1M+

Rarity

First purchase in 4 months

Confirmed open-market purchases by the same insider in the available history

Largest by this insider

No

Compared with 50 earlier confirmed purchases

Cluster activity

No other insider purchases within 30 days

Distinct insiders at the same issuer with confirmed open-market purchases

Timing vs results

22 days after results of Jul 14, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $1,060.38 on Aug 5, 2026, 48% above its 52-week low and 8% below its high, after a 3% drop over the previous 30 trading days

52-week range $715.95 (Aug 21, 2025) to $1,152.07 (Jul 15, 2026), 79% of the way up, from 251 adjusted closes. 30 trading days earlier: $1,094.44 on Jun 23, 2026. Describes the past only, not a forecast

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

After it was reported

After	Stock	S&P 500	Difference
7 days	-0.0%	-1.4%	+1.4%
30 days	-4.9%	-2.0%	-2.9%

Past results only. Not a forecast.

Source receipt

Record ID: 0000886982-26-000495
Filed / recorded: Aug 14, 2026, 1:51 AM UTC
Added to OQRO: Oct 2, 2026, 3:52 AM UTC
Parser: form4-xml-v1
Data quality: Needs review
Issuer: Attovia Therapeutics, Inc.
Issuer CIK: 2058707
Ticker: ATTO
Reporting person: GOLDMAN SACHS GROUP INC
Relationship: Other
Security: Common Stock
Table: Non-derivative (Table I)
Transaction date: Aug 5, 2026
Transaction code: P
Shares / units: 85,000
Price per share: $21.00
Acquired / disposed: Acquired (A)
Shares owned after: 85,000
Ownership form: Indirect — See Footnotes
Amendment: No

Footnotes from the filing

Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any such Reporting Person is the beneficial owner of, or has any pecuniary interest in, such securities for purposes of Section 16 of the Exchange Act, or for any other purpose.
These transactions in the common stock of the Issuer were effected by Goldman Sachs & Co. LLC ("GS&Co") acting as a market maker in the ordinary course of business. Without conceding market making trades in the ordinary course of business can result in liability under Section 16(b) of the Exchange Act, the amount of profit potentially recoverable by the Issuer from the reported transactions in the event that they were subject to Section 16(b) will be remitted to the Issuer.